Wellington Management Group LLP increased its investment in MannKind Corporation by purchasing 4,561,628 additional shares. A recent SEC Form 13F filing revealed this 138.9% surge in the firm's holdings.
Wellington now owns 7,844,807 shares of the biopharmaceutical company. This position represents approximately 2.44% of MannKind's total outstanding stock. The total value of the investment reached $33.42 million.
This move by a major institutional investor signals conviction in the small-cap biotech firm's prospects. Such significant acquisitions often influence broader investor sentiment toward the company.